http://www.ncbi.nlm.nih.gov/pubmed/27166128
CONCLUSIONS:
CHB patients who receive statin therapy have a dose-dependent reduction in the risk of cirrhosis and its decompensation.Am J Gastroenterol advance online publication, 10 May 2016; doi:10.1038/ajg.2016.179.